189 related articles for article (PubMed ID: 24433040)
1. Prolactin/Stat5 and androgen R1881 coactivate carboxypeptidase-D gene in breast cancer cells.
Koirala S; Thomas LN; Too CK
Mol Endocrinol; 2014 Mar; 28(3):331-43. PubMed ID: 24433040
[TBL] [Abstract][Full Text] [Related]
2. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
Carsol JL; Gingras S; Simard J
Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
[TBL] [Abstract][Full Text] [Related]
3. Prolactin and androgen R1881 induce pro-survival carboxypeptidase-D and EDD E3 ligase in triple-negative and HER2+ breast cancer.
MacDonald TM; Thomas LN; Gupta A; Barnes PJ; Too CK
Am J Cancer Res; 2020; 10(5):1321-1343. PubMed ID: 32509382
[TBL] [Abstract][Full Text] [Related]
4. Prolactin- and testosterone-induced carboxypeptidase-D correlates with increased nitrotyrosines and Ki67 in prostate cancer.
Thomas LN; Merrimen J; Bell DG; Rendon R; Too CK
Prostate; 2015 Nov; 75(15):1726-36. PubMed ID: 26202060
[TBL] [Abstract][Full Text] [Related]
5. Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro.
Thomas LN; Chedrawe ER; Barnes PJ; Too CKL
Breast Cancer Res Treat; 2017 Jul; 164(1):27-40. PubMed ID: 28364216
[TBL] [Abstract][Full Text] [Related]
6. Carboxypeptidase-D is elevated in prostate cancer and its anti-apoptotic activity is abolished by combined androgen and prolactin receptor targeting.
Thomas LN; Merrimen J; Bell DG; Rendon R; Goffin V; Too CK
Prostate; 2014 May; 74(7):732-42. PubMed ID: 24615730
[TBL] [Abstract][Full Text] [Related]
7. Prolactin and estrogen up-regulate carboxypeptidase-d to promote nitric oxide production and survival of mcf-7 breast cancer cells.
Abdelmagid SA; Too CK
Endocrinology; 2008 Oct; 149(10):4821-8. PubMed ID: 18535109
[TBL] [Abstract][Full Text] [Related]
8. Two androgen response elements in the androgen receptor coding region are required for cell-specific up-regulation of receptor messenger RNA.
Dai JL; Burnstein KL
Mol Endocrinol; 1996 Dec; 10(12):1582-94. PubMed ID: 8961268
[TBL] [Abstract][Full Text] [Related]
9. Induction of multidrug resistance transporter ABCG2 by prolactin in human breast cancer cells.
Wu AM; Dalvi P; Lu X; Yang M; Riddick DS; Matthews J; Clevenger CV; Ross DD; Harper PA; Ito S
Mol Pharmacol; 2013 Feb; 83(2):377-88. PubMed ID: 23150485
[TBL] [Abstract][Full Text] [Related]
10. Prolactin induction of insulin gene transcription: roles of glucose and signal transducer and activator of transcription 5.
Fleenor DE; Freemark M
Endocrinology; 2001 Jul; 142(7):2805-10. PubMed ID: 11415999
[TBL] [Abstract][Full Text] [Related]
11. The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.
Linher-Melville K; Singh G
BMC Cancer; 2014 Jun; 14():415. PubMed ID: 24913037
[TBL] [Abstract][Full Text] [Related]
12. Prolactin induces up-regulation of its cognate receptor in breast cancer cells via transcriptional activation of its generic promoter by cross-talk between ERα and STAT5.
Kavarthapu R; Tsai Morris CH; Dufau ML
Oncotarget; 2014 Oct; 5(19):9079-91. PubMed ID: 25193864
[TBL] [Abstract][Full Text] [Related]
13. Role of c-Myb during prolactin-induced signal transducer and activator of transcription 5a signaling in breast cancer cells.
Fang F; Rycyzyn MA; Clevenger CV
Endocrinology; 2009 Apr; 150(4):1597-606. PubMed ID: 19036881
[TBL] [Abstract][Full Text] [Related]
14. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
15. Androgens down-regulate the expression of the human homologue of paternally expressed gene-3 in the prostatic adenocarcinoma cell line LNCaP.
Ulrix W; Swinnen JV; Heyns W; Verhoeven G
Mol Cell Endocrinol; 1999 Sep; 155(1-2):69-76. PubMed ID: 10580840
[TBL] [Abstract][Full Text] [Related]
16. Two tandemly linked interferon-gamma-activated sequence elements in the promoter of glycosylation-dependent cell adhesion molecule 1 gene synergistically respond to prolactin in mouse mammary epithelial cells.
Hou Z; Srivastava S; Mistry MJ; Herbst MP; Bailey JP; Horseman ND
Mol Endocrinol; 2003 Oct; 17(10):1910-20. PubMed ID: 12869589
[TBL] [Abstract][Full Text] [Related]
17. Testosterone and prolactin increase carboxypeptidase-D and nitric oxide levels to promote survival of prostate cancer cells.
Thomas LN; Morehouse TJ; Too CK
Prostate; 2012 Mar; 72(4):450-60. PubMed ID: 21688280
[TBL] [Abstract][Full Text] [Related]
18. Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells.
Buser AC; Gass-Handel EK; Wyszomierski SL; Doppler W; Leonhardt SA; Schaack J; Rosen JM; Watkin H; Anderson SM; Edwards DP
Mol Endocrinol; 2007 Jan; 21(1):106-25. PubMed ID: 16973758
[TBL] [Abstract][Full Text] [Related]
19. Histone H1 and Chromosomal Protein HMGN2 Regulate Prolactin-induced STAT5 Transcription Factor Recruitment and Function in Breast Cancer Cells.
Schauwecker SM; Kim JJ; Licht JD; Clevenger CV
J Biol Chem; 2017 Feb; 292(6):2237-2254. PubMed ID: 28035005
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone- and prolactin-induced proliferation of insulinoma cells, INS-1, depends on activation of STAT5 (signal transducer and activator of transcription 5).
Friedrichsen BN; Galsgaard ED; Nielsen JH; Møldrup A
Mol Endocrinol; 2001 Jan; 15(1):136-48. PubMed ID: 11145745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
